Spironolactone, potassium chloride and hyperkalemia in patients with kidney failure
Elo, H.
Duodecim; Laaketieteellinen Aikakauskirja 108(19): 1708-1710
1992
ISSN/ISBN: 0012-7183 PMID: 1366200 Document Number: 398615
Document emailed within 1 workday
Related Documents
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910Hrabac, B.; Stranjak, M.; Hodzić, S. 1991: The effect of suxamethonium chloride on serum potassium levels during kidney transplantation Arhiv Za Higijenu Rada i Toksikologiju 42(3): 303-307
el-Din, M.M.; Malik, K.U. 1987: Mechanism of norepinephrine release elicited by renal nerve stimulation, veratridine and potassium chloride in the isolated rat kidney Journal of Pharmacology and Experimental Therapeutics 243(1): 76-85
Larkin, R.J.; Atlas, S.A.; Donohue, T.J. 2000: Spironolactone in patients with heart failure New England Journal of Medicine 342(2): 132-133; Author Reply 133-134
Brilla, C. 1999: Spironolactone advantageous to heart failure patients Fortschritte der Medizin 117(14): 48-49
Wangroongsub, Y.; Tanavalee, A.; Wilairatana, V.; Ngarmukos, S. 2010: Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study Journal of the Medical Association of Thailand 93(7): 805-811
Kjeldsen, K. 2004: Spironolactone and potassium Ugeskrift for Laeger 166(48): 4392; Author Reply 4392-3
Calderón-Ortiz, R.; Colton-Verge, P.; Muñiz-Ortega, M.; Lespier, L.; Córdova, H.éc. 2011: Life threatening hyperkalemia chronic kidney diseases patients treated with trimethoprim-sulfamethoxazole: a case series Boletin de la Asociacion Medica de Puerto Rico 103(3): 15-17
Glänzer, K.; Schlebusch, H.; Sorger, M.; Pannenbecker, D.; Krück, F. 1984: Influence of intravenous Mg++ solutions on renal excretion of potassium, sodium, calcium, chloride, intraleukocytic potassium and peripheral vascular resistance: a metabolic and hemodynamic study in normal volunteers Magnesium 3(4-6): 324-338
Haberland, K.; Glaubitt, D.; Fejér, F.L. 1974: Bone marrow scanning in patients with terminal kidney failure as well as in patients with allogenous kidney transplantation Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 743-746
Bando, H.; Murao, Y.; Aoyagi, U.; Hirakawa, A.; Iwase, M.; Nakatani, T. 2010: Extreme hyperkalemia in a patient with a new glyphosate potassium herbicide poisoning: report of a case Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 23(3): 246-249
Bogolepov, N.K.; Burd, G.S.; Ambartsumian, R.G. 1971: Sodium, potassium, calcium and chloride levels in the blood serum of patients with acute cerebral circulation disorders Klinicheskaia Meditsina 49(9): 33-35
Skvortsov, A.A.; Mareev, V.Y.; Chelmakina, S.M.; Baklanova, N.A.; Belenkov, I.N. 2007: Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy Kardiologiia 47(10): 12-23
Ferrara, A.; Ferrario, E. 1979: The use of oral potassium chloride (BS 560) in the treatment of mixed acid-base imbalance in patients with chronic broncho-pulmonary diseases Minerva Medica 70(1): 83-88
Nash, D.T. 1977: Antihypertensive effect and serum potassium homeostasis: comparison of hydrochlorothiazide and spironolactone alone and in combination Journal of Medicine 8(5): 367-377
Lamarche, M.; Royer, R. 1971: Effect of a spironolactone, potassium canrenoate, on arrhythmia of the isolated auricle induced by a digitalic drug Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(6): 1432-1433
Tosti-Croce, C.; Mantellini, R.; Fanti, P.; Sciarra, F. 1983: Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension Minerva Medica 74(14-15): 791-797
Neĭmark, M.I. 1984: Treatment and prevention of respiratory failure in chronic kidney failure patients undergoing hemodialysis Klinicheskaia Meditsina 62(6): 66-70
Klímová, D.; Vanĕcek, V. 1983: Connecting patients with chronic kidney failure to the artificial kidney. 10 years' experience at the Strahov Hemodialysis Center Casopis Lekaru Ceskych 122(34): 1030-1033
Shcherbakova, E.G.; Varakina, N.I.; Iarovaia, G.A.; Belorusov, O.S.; Dotsenko, V.L.; Vorob'eva, L.S. 1991: Status of the kallikrein-kinin system, proteinase inhibitors and nonspecific resistance factors in patients with chronic kidney failure on hemodialysis as well as in kidney transplant recipients Voprosy Meditsinskoi Khimii 37(5): 40-43